News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
620,566 Results
Type
Article (43264)
Company Profile (118)
Press Release (577184)
Multimedia
Podcasts (59)
Webinars (15)
Section
Business (175116)
Career Advice (2550)
Deals (31243)
Drug Delivery (109)
Drug Development (76314)
Employer Resources (146)
FDA (14590)
Job Trends (13286)
News (303636)
Policy (29517)
Tag
Academia (2633)
Academic (1)
Accelerated approval (12)
Adcomms (29)
Allergies (98)
Alliances (43538)
ALS (115)
Alzheimer's disease (1523)
Antibody-drug conjugate (ADC) (165)
Approvals (14571)
Artificial intelligence (309)
Autoimmune disease (32)
Automation (20)
Bankruptcy (331)
Best Places to Work (10608)
BIOSECURE Act (20)
Biosimilars (128)
Biotechnology (90)
Bladder cancer (97)
Brain cancer (34)
Breast cancer (366)
Cancer (2919)
Cardiovascular disease (230)
Career advice (2152)
Career pathing (32)
CAR-T (188)
CDC (33)
Cell therapy (507)
Cervical cancer (21)
Clinical research (63058)
Collaboration (995)
Company closure (3)
Compensation (475)
Complete response letters (34)
COVID-19 (2591)
CRISPR (58)
C-suite (377)
Cystic fibrosis (102)
Data (3094)
Decentralized trials (2)
Denatured (10)
Depression (76)
Diabetes (345)
Diagnostics (6176)
Digital health (18)
Diversity (5)
Diversity, equity & inclusion (40)
Drug discovery (141)
Drug pricing (125)
Drug shortages (26)
Duchenne muscular dystrophy (151)
Earnings (68267)
Editorial (43)
Employer branding (21)
Employer resources (135)
Events (93659)
Executive appointments (889)
FDA (16299)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (4)
Frontotemporal dementia (9)
Funding (891)
Gene editing (128)
Generative AI (24)
Gene therapy (415)
GLP-1 (790)
Government (4373)
Grass and pollen (6)
Guidances (217)
Healthcare (17271)
HIV (43)
Huntington's disease (31)
IgA nephropathy (42)
Immunology and inflammation (176)
Immuno-oncology (11)
Indications (38)
Infectious disease (2774)
Inflammatory bowel disease (151)
Inflation Reduction Act (10)
Influenza (68)
Intellectual property (119)
Interviews (534)
IPO (14281)
IRA (49)
Job creations (3037)
Job search strategy (1766)
Kidney cancer (15)
Labor market (37)
Layoffs (486)
Leadership (26)
Legal (6711)
Liver cancer (80)
Longevity (10)
Lung cancer (424)
Lymphoma (209)
Machine learning (11)
Management (51)
Manufacturing (391)
MASH (103)
Medical device (11667)
Medtech (11672)
Mergers & acquisitions (17661)
Metabolic disorders (848)
Multiple sclerosis (98)
NASH (23)
Neurodegenerative disease (149)
Neuropsychiatric disorders (42)
Neuroscience (2252)
NextGen: Class of 2025 (5916)
Non-profit (4193)
Now hiring (43)
Obesity (408)
Opinion (244)
Ovarian cancer (102)
Pain (113)
Pancreatic cancer (126)
Parkinson's disease (183)
Partnered (20)
Patents (309)
Patient recruitment (170)
Peanut (48)
People (55729)
Pharmaceutical (30)
Pharmacy benefit managers (15)
Phase I (19448)
Phase II (27651)
Phase III (21175)
Pipeline (1697)
Policy (210)
Postmarket research (2444)
Preclinical (8072)
Press Release (72)
Prostate cancer (140)
Psychedelics (44)
Radiopharmaceuticals (241)
Rare diseases (483)
Real estate (4950)
Recruiting (58)
Regulatory (21034)
Reports (30)
Research institute (2235)
Resumes & cover letters (373)
Rett syndrome (10)
RNA editing (8)
RSV (52)
Schizophrenia (100)
Series A (154)
Series B (102)
Service/supplier (6)
Sickle cell disease (61)
Special edition (15)
Spinal muscular atrophy (149)
Sponsored (32)
Startups (3063)
State (2)
Stomach cancer (15)
Supply chain (70)
Tariffs (55)
The Weekly (48)
Vaccines (784)
Venture capital (50)
Weight loss (260)
Women's health (36)
Worklife (17)
Date
Today (86)
Last 7 days (489)
Last 30 days (1668)
Last 365 days (28983)
2025 (16854)
2024 (32843)
2023 (36924)
2022 (47874)
2021 (51585)
2020 (49984)
2019 (42769)
2018 (32535)
2017 (29801)
2016 (28711)
2015 (33866)
2014 (26262)
2013 (21667)
2012 (22920)
2011 (24136)
2010 (21976)
Location
Africa (794)
Alabama (58)
Alaska (5)
Arizona (181)
Arkansas (12)
Asia (37283)
Australia (7274)
California (6885)
Canada (2325)
China (659)
Colorado (286)
Connecticut (290)
Delaware (194)
Europe (83013)
Florida (1076)
Georgia (227)
Idaho (59)
Illinois (603)
India (28)
Indiana (323)
Iowa (14)
Japan (240)
Kansas (98)
Kentucky (29)
Louisiana (15)
Maine (65)
Maryland (975)
Massachusetts (5072)
Michigan (259)
Minnesota (393)
Mississippi (3)
Missouri (98)
Montana (26)
Nebraska (23)
Nevada (77)
New Hampshire (66)
New Jersey (2021)
New Mexico (22)
New York (1942)
North Carolina (1023)
North Dakota (9)
Northern California (3030)
Ohio (211)
Oklahoma (12)
Oregon (26)
Pennsylvania (1456)
Puerto Rico (17)
Rhode Island (32)
South America (1076)
South Carolina (31)
South Dakota (1)
Southern California (2653)
Tennessee (108)
Texas (1083)
United States (25683)
Utah (215)
Virginia (188)
Washington D.C. (65)
Washington State (598)
West Virginia (4)
Wisconsin (61)
620,566 Results for "aravive biologics formerly known as ruga corporation".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Averna Therapeutics, formerly known as Exsilio Therapeutics, Appoints Thomas M. Barnes, Ph.D., as Chief Executive Officer
January 27, 2025
·
3 min read
FDA
After Prasad’s Ouster, Makary Looks for Better Drug, Biologic Alignment at FDA
The FDA has denied that it plans to combine the Center for Drug Evaluation and Research and Center for Biologics Evaluation and Research into one entity.
August 1, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Biocon Biologics Expands Diabetes Portfolio with FDA Approval of Kirsty™, the First and Only Interchangeable Rapid-Acting Insulin Aspart in the United States
July 16, 2025
·
8 min read
Press Releases
Vivex Biologics, Inc. Completes Subject Enrollment for its ASCEND Trial Evaluating VIA Disc NP™ for Symptomatic Disc Degeneration
July 30, 2025
·
2 min read
Breast cancer
AstraZeneca, Daiichi Sankyo’s ADC Wins First Approval Despite Mixed Data
Datroway, formerly known as Dato-DXd, significantly improved median progression-free survival in a Phase III study but failed to do so for overall survival.
January 21, 2025
·
2 min read
·
Tristan Manalac
Press Releases
European Medicines Agency Grants Bexobrutideg (NX-5948) Orphan Drug Designation for the Treatment of Lymphoplasmacytic Lymphoma, also Known as Waldenström Macroglobulinemia
July 8, 2025
·
6 min read
Press Releases
NurExone Biologic Inc. Announces First Quarter 2025 Financial Results and Provides Corporate Update
May 27, 2025
·
13 min read
Press Releases
AGC Biologics Expands Cell Therapy Development Operations to Asia to Serve Growing Market Need
June 26, 2025
·
3 min read
Press Releases
Solvias to Speak at Festival of Biologics 2025 on Building Robust CMC Assays for Biologic Therapies
April 23, 2025
·
2 min read
Press Releases
Celltrion’s Remdantry™, previously known as Inflectra®, will be available in Canada as of April 1, 2025
March 27, 2025
·
3 min read
1 of 62,057
Next
